Cargando…
Complete remission of combined pulmonary large cell neuroendocrine carcinoma: a case report
Pulmonary large cell neuroendocrine carcinoma (LCNEC), which accounts for approximately 1% of all lung cancers, is a rare and highly aggressive malignancy with a poor prognosis. Therefore, it is important to devise an effective treatment strategy. In the treatment of locally advanced complex LCNEC,...
Autores principales: | Xu, Jian, Feng, Qi, Chen, Yong, Liu, Xiu-lan, Jiang, Ou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573517/ https://www.ncbi.nlm.nih.gov/pubmed/34738481 http://dx.doi.org/10.1177/03000605211055387 |
Ejemplares similares
-
Pulmonary Combined Large Cell Neuroendocrine Carcinoma
por: Li, Meihui, et al.
Publicado: (2022) -
Pulmonary Large Cell Neuroendocrine Carcinoma
por: Yang, Lan, et al.
Publicado: (2022) -
Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
por: Kadota, Naoki, et al.
Publicado: (2021) -
A case of large cell neuroendocrine carcinoma of the bladder with prolonged spontaneous remission
por: Chong, Vincent, et al.
Publicado: (2017) -
Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma
por: Liang, Zuoyu, et al.
Publicado: (2022)